APOE and Alzheimer disease: We examined the presence of apoE species in CSF samples by SDS-PAGE and western blot under reducing conditions (in presence of the reducing agent β-mercaptoethanol that breaks disulfide bonds) from a cohort of control and AD patients from Gothenburg (Sweden; see Table 1) expressing different APOE genotypes.